Back to results

CompletedPhase 2

A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

NCT03007888

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Investigator 110

Little Rock, Arkansas, United States

+10 additional locations

View on ClinicalTrials.gov